Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
122.22%
0%
122.22%
6 Months
-31.03%
0%
-31.03%
1 Year
-50.0%
0%
-50.0%
2 Years
-79.59%
0%
-79.59%
3 Years
-84.85%
0%
-84.85%
4 Years
-96.91%
0%
-96.91%
5 Years
-98.04%
0%
-98.04%
Genedrive Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-16.47%
EBIT Growth (5y)
-2.17%
EBIT to Interest (avg)
-5.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.10
Tax Ratio
6.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.41
EV to EBIT
0.15
EV to EBITDA
0.16
EV to Capital Employed
-0.85
EV to Sales
-0.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-161.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jun'23
Jun'23
Jun'22
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-5.00
-5.40
7.41%
Interest
0.00
0.00
Exceptional Items
-0.80
0.00
Consolidate Net Profit
-5.20
-4.70
-10.64%
Operating Profit Margin (Excl OI)
-94,981.80%
-114,591.80%
1,961.00%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2023 is 0.00% vs -100.00% in Jun 2022
Consolidated Net Profit
YoY Growth in year ended Jun 2023 is -10.64% vs -571.43% in Jun 2022
About Genedrive Plc 
Genedrive Plc
Pharmaceuticals & Biotechnology
Genedrive Plc is a United Kingdom-based holding company engaged in molecular diagnostics business. The Company provides a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Genedrive is a small polymerase chain reaction (PCR) platform, which enables nucleic acid amplification and detection from various sample types, including plasma, sputum and buccal swabs. Genedrive system includes Genedrive hepatitis C virus (HCV) ID Kit for detection of Hepatitis C, and Genedrive IL28B ID Kit for the detection of Interleukin 28B genotyping status.
Company Coordinates 
Company Details
48 Grafton Street , MANCHESTER None : M13 9XX
Registrar Details






